IDH2 and neoplasm: Indeed, elevated serum levels of R‐2‐HG have been reported in several types of IDH‐mutant tumors [25, 26, 27], explaining how the net outcome of R‐2‐HG accumulation results in survival benefit of tumor cells, despite its potential to disturb several metabolic pathways, thereby, diminishing cellular fitness.